Evidence map›Paper›PMID 37294893›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2023

Chemerin is resident to vascular tunicas and contributes to vascular tone.

Emma Wabel, Alexis Orr, Emma D Flood, Janice M Thompson, Huirong Xie, Elena Y Demireva, Bana Abolibdeh, Darcy Honke Hulbert, Adam E Mullick, Hannah Garver and 3 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Novel role of vascular chemerin in blood vessel tone.American journal of physiology. Heart and circulatory physiology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Emma WabelDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States.ORCID 0000-0002-5820-5645
Alexis OrrDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States.
Emma D FloodDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States.
Janice M ThompsonDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States.
Huirong XieTransgenic and Genome Editing Facility, Research Technology Support Facility, and Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan, United States.
Elena Y DemirevaTransgenic and Genome Editing Facility, Research Technology Support Facility, and Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan, United States.
Bana AbolibdehTransgenic and Genome Editing Facility, Research Technology Support Facility, and Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan, United States.
Darcy Honke HulbertCardiovascular Division, Campus Animal Resources, Michigan State University, East Lansing, Michigan, United States.
Adam E MullickIonis Pharmaceuticals, Carlsbad, California, United States.ORCID 0000-0003-4600-961X
Hannah GarverDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States.
Gregory D FinkDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States.ORCID 0000-0003-4099-986X
Theodore A KungSection of Plastic and Reconstructive Surgery, Department of Surgery, Michigan Medicine, Ann Arbor, Michigan, United States.
Stephanie W WattsDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States.ORCID 0000-0002-9653-6357
Michigan United · USIonis Pharmaceuticals (United States) · US

Funding

American Heart Association-American Stroke Association 19TPA34850014
6 · The paper itself

Abstract

The adipokine chemerin may support blood pressure, evidenced by a fall in mean arterial pressure after whole body antisense oligonucleotide (ASO)-mediated knockdown of chemerin protein in rat models of normal and elevated blood pressure. Although the liver is the greatest contributor of circulating chemerin, liver-specific ASOs that abolished hepatic-derived chemerin did not change blood pressure. Thus, other sites must produce the chemerin that supports blood pressure. We hypothesize that the vasculature is a source of chemerin independent of the liver that supports arterial tone. RNAScope, PCR, Western blot analyses, ASOs, isometric contractility, and radiotelemetry were used in the Dahl salt-sensitive (SS) rat (male and female) on a normal diet. Retinoic acid receptor responder 2 (

Indexed as

Blood VesselsChemokinesAnimalsAortaGene Knockdown TechniquesLiverMuscle, Smooth, VascularRatsChemokinesRarres2 protein, ratadipokineblood pressurechemerinvascular tonevessel physiology

Identifiers

PMID37294893
PMCPMC11467446
OpenAlexW4379980633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.